Risk of adverse events after completion of therapy for childhood acute lymphoblastic leukemia.

Pui, Ching-Hon

Risk of adverse events after completion of therapy for childhood acute lymphoblastic leukemia. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Nov 2005 - 7936-41 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

0732-183X

10.1200/JCO.2004.01.0033 doi


Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Child
Child, Preschool
Combined Modality Therapy
Cranial Irradiation
Etoposide--administration & dosage
Female
Humans
Infant
Male
Precursor Cell Lymphoblastic Leukemia-Lymphoma--mortality
Prognosis
Remission Induction
Risk Factors
Survival Rate
Teniposide--administration & dosage